الفهرس 
AcknowledmentsOnly 14 pages are availabe for public view
 |  | from | 136 |  |  |
| | | from | 136 | | |
Abstract
Surfactant replacement therapy has been available for about 37 years, revolutionising neonatal respiratory care after its introduction in the 1980s.
Along with antenatal steroids, surfactants improve survival for preterm babies and they are now recommended routinely as early in the course of respiratory distress syndrome (RDS) as possible.
The present study aimed to evaluate the use of surfactant for Respiratory Distress Syndrome (RDS) in premature babies admitted at NICU of Assiut university children hospital during the period from 1st of January to 31st of december 2016 using European Consensus Guidelines on the Management – 2013 update, modified by The Egyptian Consensus on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants 2014.
The study included 50 cases with respiratory distress syndrome who received surfactant therapy.
Data of the study showed that treatment regimens for cases of RDS in Assiut University Children Hospital partially followed the reference standard of the study.
Data of the gestational age and weight and sex were recorded in 100% of cases.
Data concerning clinical evaluation of the studied group were recorded in 100% cases.
Data concerning obstetric history and prenatal care were fulfilled well but there is no records concerning receiving a course of antibiotics if there is preterm, pre-labour rupture of membranes nor short term tocolytic drugs. Also the data showed that only 28% of mothers received a course of prenatal steroids if preterm labour is expected.
Data concerning delivery room stabilization were fulfilled well but there is no records concerning delayed cord clamping and there is no available CPAP at the delivery room nor plastic bag for stabilization of preterm baby with respiratory ditress syndrome.
Data concerning surfactant therapy were fulfilled well but there is no data that any case received prophylactic surfactant therapy neither with nor without INSURE technique.
Data concerning respiratory support were fulfilled well but no cases received CPAP as a 1st line respiratory support for any spontaneously breathing preterm with RDS at delivery room and no cases received CPAP with early rescue surfactant which is now considered the optimal management for babies with RDS.
Data concerning supportive care were fulfilled in 100% of cases but no cases received enteral feeding from the 1st day which is strongly recommended with careful fluid balance for early aggressive nutritional support.
Data concerning prognosis showed that the vast majority of dead cases were below 32 weeks and below 1 KG.